Ilia I. Ouspenski

Array ( [id] => 6428665 [patent_doc_number] => 20100168400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Superagonistic Anti-CD28 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/554180 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9037 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168400.pdf [firstpage_image] =>[orig_patent_app_number] => 12554180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639555 [patent_doc_number] => 08017582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Immunostimulatory compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/553770 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 29857 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017582.pdf [firstpage_image] =>[orig_patent_app_number] => 12553770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159734 [patent_doc_number] => 20110159023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'PD-1 ANTAGONISTS AND METHODS FOR TREATING INFECTIOUS DISEASE' [patent_app_type] => utility [patent_app_number] => 13/061048 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25880 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159023.pdf [firstpage_image] =>[orig_patent_app_number] => 13061048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014915 [patent_doc_number] => 20110223188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'TARGETED COSTIMULATORY POLYPEPTIDES AND METHODS OF USE TO TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 13/060909 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30633 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223188.pdf [firstpage_image] =>[orig_patent_app_number] => 13060909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220007 [patent_doc_number] => 20100055102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'COMPOSITIONS OF PD-1 ANTAGONISTS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/547129 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25649 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055102.pdf [firstpage_image] =>[orig_patent_app_number] => 12547129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487502 [patent_doc_number] => 20110236404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Methods for Protein Expression in Mammalian Cells in Serum-Free Medium' [patent_app_type] => utility [patent_app_number] => 12/542792 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20178 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236404.pdf [firstpage_image] =>[orig_patent_app_number] => 12542792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6219996 [patent_doc_number] => 20100055091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Novel GL-50 Molecules and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/542901 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 52626 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055091.pdf [firstpage_image] =>[orig_patent_app_number] => 12542901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302866 [patent_doc_number] => 20090297518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'IMMUNOPOTENTIATIVE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/538698 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13849 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297518.pdf [firstpage_image] =>[orig_patent_app_number] => 12538698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608385 [patent_doc_number] => 07993640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody' [patent_app_type] => utility [patent_app_number] => 12/537139 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4275 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993640.pdf [firstpage_image] =>[orig_patent_app_number] => 12537139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601083 [patent_doc_number] => 20100098701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/462168 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20124 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098701.pdf [firstpage_image] =>[orig_patent_app_number] => 12462168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152567 [patent_doc_number] => 08168759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Compositions monovalent for CD28 binding and methods of use' [patent_app_type] => utility [patent_app_number] => 12/505166 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 62549 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168759.pdf [firstpage_image] =>[orig_patent_app_number] => 12505166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007042 [patent_doc_number] => 20110059073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'METHOD FOR TREATING INFECTIOUS DISEASE USING MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/502920 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11453 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059073.pdf [firstpage_image] =>[orig_patent_app_number] => 12502920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8102961 [patent_doc_number] => 08153124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Method for treating cancer using monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/502915 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11562 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153124.pdf [firstpage_image] =>[orig_patent_app_number] => 12502915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551843 [patent_doc_number] => 20090285829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Medicinal Agent and Method for Curing Prostate Diseases' [patent_app_type] => utility [patent_app_number] => 12/502831 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1595 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285829.pdf [firstpage_image] =>[orig_patent_app_number] => 12502831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795372 [patent_doc_number] => 08124078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/502911 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11627 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124078.pdf [firstpage_image] =>[orig_patent_app_number] => 12502911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8115101 [patent_doc_number] => 08158767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Polypeptides and methods for making the same' [patent_app_type] => utility [patent_app_number] => 12/458466 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5302 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158767.pdf [firstpage_image] =>[orig_patent_app_number] => 12458466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485317 [patent_doc_number] => 20090275082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Mast Cell-Derived Membrane Proteins' [patent_app_type] => utility [patent_app_number] => 12/501821 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14807 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275082.pdf [firstpage_image] =>[orig_patent_app_number] => 12501821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296104 [patent_doc_number] => 20100240585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'IN VIVO CELL SURFACE ENGINEERING' [patent_app_type] => utility [patent_app_number] => 12/499488 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21961 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240585.pdf [firstpage_image] =>[orig_patent_app_number] => 12499488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4504682 [patent_doc_number] => 07914786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Compositions and methods for treating kidney disease' [patent_app_type] => utility [patent_app_number] => 12/459764 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11453 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/914/07914786.pdf [firstpage_image] =>[orig_patent_app_number] => 12459764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183966 [patent_doc_number] => 20110123550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'USE OF AN EFFICACY MARKER FOR OPTIMIZING THERAPEUTIC EFFICACY OF AN ANTI-HUMAN PD-1 ANTIBODY ON CANCERS' [patent_app_type] => utility [patent_app_number] => 13/001875 [patent_app_country] => US [patent_app_date] => 2009-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7003 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123550.pdf [firstpage_image] =>[orig_patent_app_number] => 13001875 [rel_patent_id] =>[rel_patent_doc_number] =>)